@article{cf334831a8ae4ae2bef48e64dca1a08a,
title = "Fine-Tuning Antithymocyte Globulin Dosing and Harmonizing Clinical Trial Design",
keywords = "Antilymphocyte Serum, Clinical Trials as Topic, Disease-Free Survival, Double-Blind Method, Hematopoietic Stem Cell Transplantation, Humans, Immunosuppressive Agents, Prospective Studies, T-Lymphocytes",
author = "Boelens, {Jaap Jan} and Rick Admiraal and Jurgen Kuball and Stefan Nierkens",
year = "2018",
month = apr,
day = "10",
doi = "10.1200/JCO.2017.77.1774",
language = "English",
volume = "36",
pages = "1175--1176",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams and Wilkins",
number = "11",
}